Active Ingredient: LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
Proprietary Name: PLUVICTO
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 27mCi/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215833
Product Number: 001
Approval Date: Mar 23, 2022
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information